JP2014240389A5 - - Google Patents

Download PDF

Info

Publication number
JP2014240389A5
JP2014240389A5 JP2014130313A JP2014130313A JP2014240389A5 JP 2014240389 A5 JP2014240389 A5 JP 2014240389A5 JP 2014130313 A JP2014130313 A JP 2014130313A JP 2014130313 A JP2014130313 A JP 2014130313A JP 2014240389 A5 JP2014240389 A5 JP 2014240389A5
Authority
JP
Japan
Prior art keywords
seq
group
skin
cosmetic composition
kallikrein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014130313A
Other languages
English (en)
Japanese (ja)
Other versions
JP5891266B2 (ja
JP2014240389A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2014240389A publication Critical patent/JP2014240389A/ja
Publication of JP2014240389A5 publication Critical patent/JP2014240389A5/ja
Application granted granted Critical
Publication of JP5891266B2 publication Critical patent/JP5891266B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014130313A 2008-01-21 2014-06-25 皮膚病の治療におけるセリンプロテアーゼ阻害剤の使用 Expired - Fee Related JP5891266B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2238608P 2008-01-21 2008-01-21
US61/022,386 2008-01-21
US657608P 2008-01-22 2008-01-22
US61/006,576 2008-01-22

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010542703A Division JP5615184B2 (ja) 2008-01-21 2009-01-21 皮膚病の治療におけるセリンプロテアーゼ阻害剤の使用

Publications (3)

Publication Number Publication Date
JP2014240389A JP2014240389A (ja) 2014-12-25
JP2014240389A5 true JP2014240389A5 (https=) 2015-02-12
JP5891266B2 JP5891266B2 (ja) 2016-03-22

Family

ID=40901490

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010542703A Expired - Fee Related JP5615184B2 (ja) 2008-01-21 2009-01-21 皮膚病の治療におけるセリンプロテアーゼ阻害剤の使用
JP2014130313A Expired - Fee Related JP5891266B2 (ja) 2008-01-21 2014-06-25 皮膚病の治療におけるセリンプロテアーゼ阻害剤の使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010542703A Expired - Fee Related JP5615184B2 (ja) 2008-01-21 2009-01-21 皮膚病の治療におけるセリンプロテアーゼ阻害剤の使用

Country Status (8)

Country Link
US (3) US20110130338A1 (https=)
EP (1) EP2244728B1 (https=)
JP (2) JP5615184B2 (https=)
CN (2) CN110522905A (https=)
AU (1) AU2009207394B2 (https=)
BR (1) BRPI0906167A2 (https=)
CA (1) CA2712512C (https=)
WO (1) WO2009093119A2 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110522905A (zh) 2008-01-21 2019-12-03 德莫迪斯公司 丝氨酸蛋白酶抑制剂在治疗皮肤病中的用途
EP2405925B1 (en) * 2009-03-10 2015-01-14 Med Discovery Sa Kallikrein inhibitors for the treatment of neutropenia
WO2013084425A1 (ja) 2011-12-09 2013-06-13 モメンティブ・パフォーマンス・マテリアルズ・ジャパン合同会社 シリコーンゴム発泡体用組成物、シリコーンゴム発泡体の製造方法およびシリコーンゴム発泡体
DK2883954T3 (da) 2012-08-08 2020-09-28 Daiichi Sankyo Co Ltd Peptidbibliotek og anvendelse deraf
JP6484174B2 (ja) * 2012-09-19 2019-03-20 マクカイ メモリアル ホスピタル 皮膚老化を予防及び/又は改善するためのpedf−由来ポリペプチドの使用
KR101437408B1 (ko) 2012-11-05 2014-09-05 동아대학교 산학협력단 플라스민 및 엘라스타아제 저해 활성을 갖는 산왕거미 유래의 쿠니츠 타입 세린 프로테아제 저해 단백질 및 이를 유효성분으로 포함하는 염증 억제 및 항섬유소용해용 조성물
US10807805B2 (en) 2013-05-17 2020-10-20 Intelligrated Headquarters, Llc Robotic carton unloader
EP3495293B1 (en) 2013-05-17 2023-05-03 Intelligrated Headquarters LLC Robotic carton unloader
GB201322091D0 (en) * 2013-12-13 2014-01-29 Cambridge Entpr Ltd Modified serpins for the treatment of bleeding disorders
WO2015114144A1 (en) * 2014-02-03 2015-08-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of netherton syndrome
EP3113849B1 (en) * 2014-02-26 2019-06-12 Luma Therapeutics, Inc. Ultraviolet phototherapy apparatus
JP6738280B2 (ja) * 2014-10-24 2020-08-12 株式会社 資生堂 角層剥離の抑制又は亢進に起因する肌状態を改善するための美容方法及び評価方法
MA40998A (fr) 2014-11-21 2017-09-26 Ophirex Inc Thérapies contre une envenimation, ainsi que compositions, systèmes et kits pharmaceutiques associés
US10597235B2 (en) 2016-10-20 2020-03-24 Intelligrated Headquarters, Llc Carton unloader tool for jam recovery
CN106478812B (zh) * 2016-10-21 2020-11-20 沈阳药科大学 丝氨酸蛋白酶抑制剂-3及其功能、制备方法和应用
TW202313978A (zh) * 2016-11-23 2023-04-01 美商阿尼拉製藥公司 絲胺酸蛋白酶抑制因子A1 iRNA組成物及其使用方法
SG11201909048TA (en) * 2017-04-21 2019-11-28 Genentech Inc Use of klk5 antagonists for treatment of a disease
WO2018232300A1 (en) * 2017-06-16 2018-12-20 Azitra Inc Compositions and methods for treatment of netherton syndrome with lekti expressing recombinant microbes
US20200040103A1 (en) 2018-03-14 2020-02-06 Genentech, Inc. Anti-klk5 antibodies and methods of use
EP3856761A1 (en) 2018-09-24 2021-08-04 Krystal Biotech, Inc. Compositions and methods for the treatment of netherton syndrome
PE20221906A1 (es) 2019-09-18 2022-12-23 Genentech Inc Anticuerpos anti-klk7, anticuerpos anti-klk5, anticuerpos multiespecificos anti-klk5/klk7 y metodos de uso
CN114867865A (zh) * 2019-11-21 2022-08-05 密执安大学评议会 中性粒细胞弹性蛋白酶活性的多肽抑制剂及其用途
US20230099101A1 (en) * 2020-03-06 2023-03-30 The Regents Of The University Of Michigan Serine protease inhibitors for suppressing or preventing anaphylactic reaction
CN112315897A (zh) * 2020-11-04 2021-02-05 深圳前海鹰岗生物科技有限公司 一种抑制细胞炎症反应释放治疗痛风急性发作的聚合物微针及制备方法
EP4466008A4 (en) * 2022-01-18 2025-08-20 Univ California METHOD FOR INHIBITING PROTEASE ACTIVITY IN DEGRADATION DURING AGING
JP7820193B2 (ja) * 2022-03-04 2026-02-25 株式会社ナリス化粧品 角層剥離改善剤
WO2024159008A1 (en) * 2023-01-25 2024-08-02 Quoin Pharmaceuticals, Inc. Combination treatment for netherton syndrome
CN117084936A (zh) * 2023-09-22 2023-11-21 南京盛德生物科技研究院有限公司 多萜类化合物作为激肽释放酶抑制剂在化妆品中的应用
WO2026021603A1 (zh) * 2024-07-25 2026-01-29 吉林大学第一医院 Serpina3蛋白变异体或其编码序列以及它们的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079336A (en) * 1989-06-23 1992-01-07 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production
US5252725A (en) * 1989-06-23 1993-10-12 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production
DE4214215A1 (de) * 1992-04-30 1993-11-04 Behringwerke Ag Verwendung von inhibitoren von plasminogenaktivatoren zur behandlung von entzuendungen
AUPP508798A0 (en) * 1998-08-05 1998-08-27 Biotech Australia Pty Limited Method of treating psoriasis
RU2264824C2 (ru) * 1999-06-18 2005-11-27 Йон Браги БЬЯРНАСОН Сериновые протеиназы рыб и их фармацевтическое и косметическое применение
US7105172B1 (en) * 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea
WO2002040654A2 (en) * 2000-11-14 2002-05-23 Bristol-Myers Squibb Company A human serpin secreted from lymphoid cells lsi-01
US20040097481A1 (en) * 2002-11-20 2004-05-20 Benjamin Levinson Water-soluble mesoporphyrin compounds and methods of preparation
AU2003286258B2 (en) * 2002-11-20 2006-12-21 Arriva-Prometic Inc. Composition and method for treating inflammatory diseases using protease inhibitors
CA2521410C (en) * 2003-04-04 2014-06-03 Universite De Lausanne Inhibitor proteins of a protease and use thereof
WO2005117955A1 (en) * 2004-05-19 2005-12-15 Arriva Pharmaceuticals, Inc. Treatment of atopic dermatitis with unglycosylated alpha one-antitrypsin
EP1666075A1 (en) * 2004-10-04 2006-06-07 Switch Biotech Aktiengesellschaft Wound dressing compositions, especially for delivery of protease inhibitors
WO2006090282A2 (en) * 2005-02-28 2006-08-31 Universite De Lausanne Recombinant inhibitor proteins of an hk14 protease and use thereof
GB0525999D0 (en) * 2005-12-21 2006-02-01 Ares Trading Sa Novel members of the kazal family of serine protease inhibitors
WO2009000878A1 (en) * 2007-06-28 2008-12-31 Novartis Ag Kallikrein 7 modulators
WO2009024528A1 (en) * 2007-08-17 2009-02-26 Novartis Ag Use of cyclic depsipeptides to inhibit kallikrein 7
CN110522905A (zh) 2008-01-21 2019-12-03 德莫迪斯公司 丝氨酸蛋白酶抑制剂在治疗皮肤病中的用途

Similar Documents

Publication Publication Date Title
JP2014240389A5 (https=)
Levin et al. Next generation matrix metalloproteinase inhibitors—Novel strategies bring new prospects
Siklos et al. Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors
Heutinck et al. Serine proteases of the human immune system in health and disease
Betrosian et al. Purpura fulminans in sepsis
WO2011150284A3 (en) Removal of serine proteases by treatment with finely divided silicon dioxide
EP3623470A3 (en) Factor ix variants with clotting activity in absence of their cofactor and their use for treating bleeding disorders
EA201691558A1 (ru) Удаление сериновых протеаз путем обработки тонкоизмельченным диоксидом кремния
ECSP045115A (es) INDOL-2-CARBOXAMIDAS COMO INHIBIDORES DEL FACTOR Xa
WO2013061083A3 (en) Therapeutic agents and uses thereof
MY183252A (en) Kallirein 7 modulators
CN110062757A (zh) 凝血因子XIa抑制剂及其用途
WO2008156817A3 (en) Renin inhibitors
WO2020186132A8 (en) Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
TN2009000503A1 (en) Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation
CY1107342T1 (el) Χρηση παραγωγων νιτριλιου ως φαρμακο
WO2014140103A3 (en) Thrombin sensitive coagulation factor x molecules
WO2009136997A3 (en) Inhibitors of human cathepsin l, cathepsin b, and cathepsin s
JP2020502132A5 (https=)
WO2007117559A8 (en) Renin inhibitors
WO2007099348A3 (en) Cathepsin propeptide and uses thereof
WO2020023094A3 (en) Treatment of lysosomal storage disorders
ZA200908583B (en) Substituted (oxazolidinon-5-yl-methyl)-2-thiophene-carboxamides and use thereof in the field of blood coagulation
ATE410174T1 (de) Zusammensetzung zur vorbeugung und behandlung von erkältungskrankheiten
Zupetic et al. Regulation Of Pseudomonas Aeruginosa Exoprotease And Elastase Activity By Thrombospondin-1